To fuse or not to fuse: The effects of electrostatic interactions, hydrophobic forces, and structural amphiphilicity on protein-mediated membrane destabilization

Advanced Drug Delivery Reviews

Volumn 38, Issue 3, 1999, Pages 257-277

  Fujii, Gary ^a  

^a Molecular Express Inc   (United States)

Author keywords

Defensins; Gene therapy; Glycine moments; HA2; HIV; Influenza; Liposome; Melittin; Membrane fusion

Indexed keywords

CELL MEMBRANES; ELECTROSTATICS; GENETIC ENGINEERING; HYDROPHOBICITY; PROTEINS; VIRUSES;

GENE THERAPY; LIPOSOMES;

CONTROLLED DRUG DELIVERY;

COAT PROTEIN; GLYCINE; LIPOSOME; PEPTIDE; PROTEIN; VIRUS FUSION PROTEIN;

DRUG DELIVERY SYSTEM; GENE TARGETING; GENE THERAPY; HYDROPHOBICITY; MEMBRANE; MEMBRANE FUSION; MODEL; PRIORITY JOURNAL; REVIEW;

EID: 0032767008     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(99)00032-0     Document Type: Article

References (139)

1. Miller A.D., Jolly D.J., Friedmann T., Verma I.M. A transmissible retrovirus expressing human hypoxanthine phosphoribosyltransferase (HPRT): Gene transfer into cells obtained from humans deficient in HPRT. Proc. Natl. Acad. Sci. USA. 80:1983;4709-4713.
2. Mann R., Mulligan R.C., Baltimore D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell. 33:1983;153-159.
3. Wagner E., Zatloukal K., Cotton M., Kirlappos H., Mechtler K., Curiel D.T., Birnstiel M.L. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc. Natl. Acad. Sci. USA. 89:1992;6099-6103.
4. Curiel D.T., Wagner E., Cotton M., Birnstiel M.L., Agarwal S., Li C., Loechel S., Hu P. High-efficiency gene transfer mediated by adenovirus coupled to DNA-polylysine complexes. Hum. Gene Ther. 3:1992;147-154.
5. Nabel E.G., Plautz G., Nabel G.J. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science. 249:1990;1285-1288.
6. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., Northrop J.P., Ringold G.M., Danielsen M. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA. 84:1987;7413-7417.
7. Jarnagin W.R., Debs R.J., Wang S., Bissell D.M. Cationic lipid-mediated transfection of liver cells in primary culture. Nucleic Acids Res. 20:1992;4205-4211.
8. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeWitt C.M., Friedman A., et al. Heterologous protection against Influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
9. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
10. Fazio V.M., Fazio S., Rinaldi M., Catani M.V., Zotti S., Ciafre S.A., Seripa D., Ricci G., Farace M.G. Accumulation of human apolipoprotein-e in rat plasma after in vivo intramuscular injection of naked DNA. Biochem. Biophys. Res. Commun. 200:1994;298-305.
11. Hu S., Bruszewski J., Nicolson M., Tseng J., Hsu R., Bosselman R. Generation of competent virus in the REV helper cell line C3. Virology. 159:1987;446-449.
12. Donahue R.E., Kessler S.W., Bodine D., McDonagh K., Dunbar C., Goodman S., Agricola B., Byrne E., Raffeld M., Moen R., et al. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J. Exp. Med. 176:1992;1125-1135.
13. Singhal A., Huang L. Direct gene transfer by liposomes. J. Liposome Res. 4:1994;289-299.
14. Gershon H., Ghirlando R., Guttman S.B., Minsky A. Mode of formation and structural features of DNA-cationic liposome complexes used for transfection. Biochemistry. 32:1993;7143-7151.
15. Leserman L., Machy P., Zelphati O. Immunoliposome-mediated delivery of nucleic acids: A review of our laboratory's experience. J. Liposome Res. 4:1994;107-119.
16. Senior J.H., Trimble K.R., Maskiewicz R. Interaction of positively-charged liposomes with blood: implications for their application in vivo. Biochim. Biophys. Acta. 1070:1991;173-179.
17. Mukherjee A.B., Orloff S., Butler J.D., Triche T., Lalley P., Schulman J.D. Entrapment of metaphase chromosomes into phospholipid vesicles (lipochromosomes): Carrier potential in gene transfer. Proc. Natl. Acad. Sci. USA. 75:1978;1361-1365.
18. Fraley R., Subramani S., Berg P., Papahadjopoulos D. Introduction of liposome-encapsulated SV40 DNA into cells. J. Biol. Chem. 255:1980;10431-10435.
19. Papahadjopoulos D., Cowden M., Kimelberg H. Role of cholesterol in membranes: effects on phospholipid-protein interactions, membrane permeability and enzymatic activity. Biochim. Biophys. Acta. 330:1973;8-26.
20. Papahadjopoulos D., Jacobson K., Nir S., Isac T. Phase transitions in phospholipid vesicles. Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol. Biochim. Biophys. Acta. 311:1973;330-348.
21. Gregoriadis G., Davis C. Stability of liposomes in vivo and in vitro is promoted by their cholesterol content and the presence of blood cells. Biochem. Biophys. Res. Commun. 89:1979;1287-1293.
22. Kirby C., Clarke J., Gregoriadis G. Cholesterol content of small unilamellar liposomes controls phospholipid loss to high density lipoproteins in the presence of serum. FEBS Lett. 111:1980;324-328.
23. Surolia A., Bachhawat B.K. Monosialoganglioside liposome-entrapped enzyme uptake by hepatic cells. Biochim. Biophys. Acta. 497:1977;760-765.
24. Gregoriadis G. Fate of liposomes in vivo and its control: a historical perspective. Lasic D.D., Martin F.J. Stealth Liposomes. 1995;7-12 CRC Press, Boca Raton, FL.
25. Proffitt R.T., Williams L.E., Presant C.A., Tin G.W., Uliana J.A., Gamble R.C., Baldeschwieler J.D. Tumor-imaging potential of liposomes loaded with In-111-NTA: biodistribution in mice. J. Nucl. Med. 24:1983;45-51.
26. Papahadjopoulos D., Allen T.M., Gabizon A., Mayhew E., Matthay K., Huang S.K., Lee K.D., Woodle M.C., Lasic D.D., Redemann C., et al. Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA. 88:1991;11460-11464.
27. Martin F., MacDonald R. Liposomes can mimic virus membranes. Nature. 252:1974;161-163.
28. Arscott P.G., Li A., Bloomfield V.A. Condensation of DNA by trivalent cations. 1. Effects of DNA length and topology on the size and shape of condensed particles. Biopolymers. 30:1990;619-630.
29. Chattoraj D.K., Gosule L.C., Schellman J.A. DNA condensation with polyamines. II. Electron microscopic studies. J. Mol. Biol. 121:1978;327-337.
30. Laemmli U.K. Characterization of DNA condensates induced by poly(ethylene oxide) and polylysine. Proc. Natl. Acad. Sci. USA. 72:1975;4288-4292.
31. Gosule L.C., Schellman J.A. DNA condensation with polyamines. I. Spectroscopic studies. J. Mol. Biol. 121:1978;311-326.
32. Kaiser D., Syvanen M., Masuda T. DNA packaging steps in bacteriophage lambda head assembly. J. Mol. Biol. 91:1975;175-186.
33. Plum G.E., Arscott P.G., Bloomfield V.A. Condensation of DNA by trivalent cations. 2. Effects of cation structure. Biopolymers. 30:1990;631-643.
34. Haynes M., Garrett R.A., Gratzer W.B. Structure of nucleic acid-poly base complexes. Biochemistry. 9:1970;4410-4416.
35. Bloomfield V.A. Condensation of DNA by multivalent cations: considerations on mechanism. Biopolymers. 31:1991;1471-1481.
36. Behr J. DNA strongly binds to micelles and vesicles containing lipopolyamines or lipointercalants. Tetrahedron Lett. 27:1986;5861-5864.
37. Mascotti D.P., Lohman T.M. Thermodynamics of single-stranded RNA and DNA interactions with oligolysines containing tryptophan. Effects of base composition. Biochemistry. 32:1993;10568-10579.
38. Blume G., Cevc G. Molecular mechanism of the lipid vesicle longevity in vivo. Biochim. Biophys. Acta. 1146:1993;157-168.
39. Williams L.E., Proffitt R.T., Lovisatti L. Possible applications of phospholipid vesicles (liposomes) in diagnostic radiology. J. Nucl. Med. Allied Sci. 28:1984;35-45.
40. Lasic D.D., Martin F.J., Gabizon A., Huang S.K., Papahadjopoulos D. Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim. Biophys. Acta. 1070:1991;187-192.
41. Surolia A., Bachhawat B.K., Podder S.K. Interaction between lectin from Ricinus communis and liposomes containing gangliosides. Nature. 257:1975;802-804.
42. Gregoriadis G., Neerunjun E.D. Control of the rate of the hepatic uptake and catabolism of liposome-entrapped proteins injected into rats: a possible therapeutic application. Eur. J. Biochem. 47:1974;179-185.
43. Jonah M.M., Cerny E.A., Rahman Y.E. Tissue distribution of EDTA encapsulated within liposomes containing glycolipids or brain phospholipids. Biochim. Biophys. Acta. 541:1978;321-333.
44. Szoka F.C., Mayhew E. Alteration of liposome disposition in vivo by bilayer situated carbohydrate. Biochim. Biophys. Res. Commun. 110:1983;140-146.
45. Spanjer H.H., Scherphof G.L. Targeting of lactosylceramide containing liposomes to hepatocytes in vivo. Biochim. Biophys. Acta. 734:1983;40-47.
46. Klibanov A.L., Khaw B.A., Nossiff N., O'Donnell S.M., Huang L., Slinkin M.A., Torchilin V.P. Targeting of macromolecular carriers and liposomes by antibodies to myosin heavy chain. Am. J. Physiol. 261:1991;60-65.
47. Derksen J.T.P., Morselt H.W.M., Scherphof G.L. Processing of different liposome markers after in vitro uptake of immunoglobulin-coated liposomes by rat liver macrophages. Biochim. Biophys. Acta. 931:1987;33-40.
48. Aragnol D., Leserman L.D. Immune clearance of liposomes inhibited by an anti-Fc receptor antibody in vivo. Proc. Natl. Acad. Sci. USA. 83:1986;2699-2703.
49. Ahmad I., Longenecker M., Samuel J., Allen T.M. Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice. Cancer Res. 53:1993;1484-1488.
50. Torchilin V.P., Klibanov A.L., Huang L., O'Donnell S., Nossiff N.D., Khaw B.A. Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium. FASEB J. 6:1992;2716-2719.
51. Hoekstra D. Membrane fusion of enveloped viruses: Especially a matter of proteins. J. Bioenerg. Biomembr. 22:1990;121-155.
52. White J.M. Viral and cellular membrane fusion proteins. Annu. Rev. Physiol. 52:1990;675-697.
53. Harter C., James P., Bachi T., Semenza G., Brunner J. Hydrophobic binding of the ectodomain of Influenza hemagglutinin to membranes occurs through the 'Fusion Peptide'. J. Biol. Chem. 264:1989;6459-6464.
54. Bullough P.A., Hughson F.M., Skehel J.J., Wiley D.C. Structure of Influenza haemagglutinin at the pH of membrane fusion. Nature. 371:1994;37-43.
55. Gordon L.M., Curtain C.C., Zhong Y.C., Kirkpatrick A., Mobley P.W., Waring A.J. The amino-terminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocyte membranes: peptide conformation, orientation and aggregation. Biochim. Biophys. Acta. 1139:1992;257-274.
56. Wharton S.A., Martin S.R., Ruigrok R.W.H., Skehel J.J., Wiley D.C. Membrane fusion by peptide analogues of influenza virus haemagglutinin. J. Gen. Virol. 69:1988;1847-1857.
57. Delahunty M.D., Rhee I., Freed E.O., Bonifacino J.S. Mutational analysis of the fusion peptide of the Human Immunodeficiency Virus type 1: identification of critical glycine residues. Virology. 218:1996;94-102.
58. Epand R.F., Martin I., Ruysschaert J.M., Epand R.M. Membrane orientation of the SIV fusion peptide determines its effect on bilayer stability and ability to promote membrane fusion. Biochem. Biophys. Res. Commun. 205:1994;1938-1943.
59. Kaiser E.T., Kézdy F.J. Amphiphilic secondary structure: Design of peptide hormones. Science. 223:1984;249-255.
60. Lucy J.A. Do hydrophobic sequences cleaved from cellular polypeptides induce membrane fusion reactions in vivo? FEBS Lett. 166:1984;223-231.
61. Fujii G., Selsted M.E., Eisenberg D. Defensins promote fusion and lysis of negatively charged membranes. Prot. Sci. 2:1993;1301-1312.
62. Ono S., Lee S., Mihara H., Aoyagi H., Kato T., Yamasaki N. Design and synthesis of basic peptides having amphipathic β-structure and their interaction with phospholipid membranes. Biochim. Biophys. Acta. 1022:1990;237-244.
63. Epand R.M., Cheetham J.J., Epand R.F., Yeagle P.L., Richardson C.D., Rockwell A., Degrado W.F. Peptide models for the membrane destabilizing actions of viral fusion proteins. Biopolymers. 32:1992;309-314.
64. Subbarao N.K., Parente R.A., Szoka F.C., Nadasdi L., Pongracz K. pH-dependent bilayer destabilization by an amphipathic peptide. Biochemistry. 26:1987;2964-2972.
65. Hong K., Vacquier V.D. Fusion of liposomes induced by a cationic protein from the acrosome granule of abalone spermatozoa. Biochemistry. 25:1986;543-549.
66. Pauling L., Corey R.B., Branson H.R. The structure of proteins: two hydrogen-bonded helical configurations of the polypeptide chain. Proc. Natl. Acad. Sci. USA. 37:1951;205-211.
67. Huxley H.E., Perutz M.F. New X-ray evidence on the configuration of polypeptide chains. Nature. 167:1951;1053-1054.
68. Schiffer M., Edmundson A.B. Use of helical wheels to represent the structures of proteins and to identify segments with helical potential. Biophys. J. 7:1967;121-135.
69. Wu T.T., Kabat E.A. An attempt to evaluate the influence of neighboring amino acids (n-1) an (n+1) on the backbone conformation of amino acid (n) in proteins. Use in predicting the three-dimensional structure of the polypeptide backbone of other proteins. J. Mol. Biol. 75:1973;13-31.
70. Garnier J. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J. Mol. Biol. 120:1978;97-120.
71. Chou P.Y., Fasman G.D. Prediction of protein conformation. Biochemistry. 13:1974;222-245.
72. Eisenberg D., Weiss R.M., Terwilliger T.C. The helical hydrophobic moment: a measure of the amphiphilicity of a helix. Nature. 299:1982;371-374.
73. Eisenberg D., Schwarz E., Komaromy M., Wall R. Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J. Mol. Biol. 179:1984;125-142.
74. Habermann V.E., Jentsch J. Sequenzanalyse des Melittins aus den tryptishcehn und peptischen Spaltstucken. Hoppe-Seyler's Z. Physiol. Chem. 348:1967;37-50.
75. Eisenberg D., Wesson M. The most highly amphiphilic α-helices include two amino acid segments in Human Immunodeficiency Virus glycoprotein 41. Biopolymers. 29:1990;171-177.
76. Fujii G., Horvath S., Woodward S., Eiserling F., Eisenberg D. A molecular model for membrane fusion based on solution studies of an amphiphilic peptide from HIV gp41. Prot. Sci. 1:1992;1454-1464.
77. Dempsey C.E. The actions of melittin on membranes. Biochim. Biophys. Acta. 1031:1990;143-161.
78. Selsted M.E., Harwig S.S.L., Ganz T., Schilling J.W., Lehrer R.I. Primary structures of three human neutrophil defensins. J. Clin. Invest. 76:1985;1436-1439.
79. Selsted M.E., Brown D.M., DeLange R.J., Harwig S.S.L., Lehrer R.I. Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J. Biol. Chem. 260:1985;4579-4584.
80. Hill C.P., Yee J., Selsted M.E., Eisenberg D. Crystal structure of defensin HNP-3, an amphiphilic dimer: Mechanisms of membrane permeabilization. Science. 251:1991;1481-1485.
81. Terwilliger T.C., Weissman L., Eisenberg D. The structure of melittin in the form I crystals and its implication for melittin's lytic and surface activities. Biophys. J. 37:1982;353-361.
82. Batenburg A.M., Hibbeln J.C.L., deKruijff B. Lipid specific penetration of melittin into phospholipid model membranes. Biochim. Biophys. Acta. 903:1987;155-165.
83. Kim J., Mosior M., Chung L.A., Wu H., McLaughlin S. Binding of peptides with basic residues to membranes containing acidic phospholipids. Biophys. J. 60:1991;135-148.
84. Papahadjopoulos D., Vail W.J., Newton C., Nir S., Jacobson K., Poste G., Lazo R. Studies on membrane fusion. II. The role of calcium-induced phase changes. Biochim. Biophys. Acta. 465:1977;579-598.
85. Stegmann T., Doms R.W., Helenius A. Protein-mediated membrane fusion. Annu. Rev. Biophys. Biophys. Chem. 18:1989;187-211.
86. Düzgünes N., Wilschut J., Fraley R., Papahadjopoulos D. Studies on the mechanism of membrane fusion. Role of head-group composition in calcium- and magnesium-induced fusion of mixed phospholipid vesicles. Biochim. Biophys. Acta. 642:1981;182-195.
87. Ishiguro R., Kimura N., Takahashi S. Orientation of fusion-active synthetic peptides in phospholipid bilayers: determination by fourier transform infrared spectroscopy. Biochemistry. 32:1993;9792-9797.
88. Weakliem C.L., Fujii G., Chang J.E., Ben-Shaul A., Gelbart W.M. Effect of tension on pore formation in drug-containing vesicles. J. Phys. Chem. 99:1995;7694-7697.
89. Fujii G., Chang J.E., Coley T., Steere B. The formation of amphotericin B ion channels in lipid bilayers. Biochemistry. 36:1997;4959-4968.
90. Wimley W.C., Selsted M.E., White S.H. Interactions between human defensins and lipid bilayers: Evidence for formation of multimeric pores. Prot. Sci. 3:1994;1362-1373.
91. Nicol F., Nir S., Szoka F.C. Effect of cholesterol and charge on pore formation in bilayer vesicles by a pH-sensitive peptide. Biophys. J. 71:1996;3288-3301.
92. Anantharamaiah G.M., Jones J.L., Brouillette C.G., Schmidt C.F., Chung B.H., Hughes T.A., Bhown A.S., Segrest J.P. Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine. J. Biol. Chem. 260:1985;10248-10255.
93. Rafalski M., Lear J.D., Degrado W.F. Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41. Biochemistry. 29:1990;7917-7922.
94. Muesing M.A., Smith D.H., Cabradilla C.D., Benton C.V., Lasky L.A., Capon D.J. Nucleic acid structure and expression of the human AIDS/Lymphadenopathy retrovirus. Nature. 313:1985;450-458.
95. Modrow S., Hahn B.H., Shaw G.M., Gallo R.C., Wong-Staal F., Wolf H. Computer-assisted analysis of envelope protein sequences of seven Human Immunodeficiency Virus isolates: Prediction of antigenic epitopes in conserved and variable regions. J. Virol. 61:1987;570-578.
96. Doms R.W., Helenius A., White J. Membrane fusion activity of the Influenza Virus hemagglutinin. The low pH-induced conformational change. J. Biol. Chem. 260:1985;2973-2981.
97. Gething M.J., Doms R.W., York D., White J. Studies on the mechanism of membrane fusion site-specific mutagenesis of the hemagglutinin of influenza virus. J. Cell Biol. 102:1986;11-23.
98. Kielian M., Jungerwirth S. Mechanisms of enveloped virus entry into cells. Mol. Biol. Med. 7:1990;17-31.
99. Gonzalez-Scarano F., Waxham M.N., Ross A.M., Hoxie J.A. Sequence similarities between Human Immunodeficiency Virus gp41 and paramyxovirus fusion proteins. AIDS Res. Hum. Retrovir. 3:1987;245-252.
100. Bosch M.L., Earl P.L., Fargnoli K., Picciafuoco S., Giombini F., Wong-Staal F., Franchini G. Identification of the fusion peptide of primate immunodeficiency viruses. Science. 244:1989;694-697.
101. 2 terminus of Influenza HA-2. J. Biol. Chem. 262:1987;6500-6505.
102. Brasseur R., Cornet B., Burny A., Vandenbranden M., Ruysschaert J.M. Mode of insertion into a lipid membrane of the N-terminal HIV gp41 peptide segment. AIDS Res. Hum. Retrovir. 4:1988;83-90.
103. Lüneberg J., Martin I., Nubler F., Ruysschaert J.M., Herrmann A. Structure and topology of the influenza virus fusion peptide in lipid bilayers. J. Biol. Chem. 270:1995;27606-27614.
104. G. Fujii, Mechanistic and structural studies on the interactions of proteins with membranes. PhD dissertation, University of California, Los Angeles, 1991, pp. 8-61.
105. Gething M.J., Bye J., Skehel J., Waterfield M. Cloning and DNA sequence of double-stranded copies of haemagglutinin genes from H2 and H3 strains elucidates antigenic shift and drift in human influenza virus. Nature. 287:1980;301-306.
106. Kowalski M., Potz J., Basiripour L., Dorfman T., Goh W.C., Terwillinger E., Dayton A., Rosen C., Haseltine W., Sodroski J. Functional regions of the envelope glycoprotein of Human Immunodeficiency Virus type 1. Science. 237:1987;1351-1355.
107. Freed E.O., Myers D.J., Risser R. Characterization of the fusion domain of the Human Immunodeficiency Virus type 1 envelope glycoprotein gp41. Proc. Natl. Acad. Sci. USA. 87:1990;4650-4654.
108. Wain-Hobson S., Sonigo P., Danos O., Cole S., Alizon M. Nucleotide sequence of the AIDS virus, LAV. Cell. 40:1985;9-17.
109. Struck D.K., Hoekstra D., Pagano R.E. Use of resonance energy transfer to monitor membrane fusion. Biochemistry. 20:1981;4093-4099.
110. McClure M.O., Marsh M., Weiss R.A. Human Immunodeficiency Virus infection of CD4-bearing cells occurs by a pH-independent mechanism. EMBO J. 7:1988;513-518.
111. Murata M., Sugahara Y., Takahashi S. pH-dependent membrane fusion activity of a synthetic twenty amino acid peptide with the same sequence as that of the hydrophobic segment of influenza virus hemagglutinin. J. Biochem. 102:1987;957-962.
112. Papahadjopoulos D., Mascarello M., Eylar E.H., Isac T. Effects of proteins on thermotropic phase transitions of phospholipid membranes. Biochim. Biophys. Acta. 401:1975;317-335.
113. Burger K.N.J., Wharton S.A., Demel R.A., Verkleij A.J. The interaction of synthetic analogs of the N-terminal fusion sequence of influenza virus with a lipid monolayer. Comparison of fusion-active and fusion-defective analogs. Biochim. Biophys. Acta. 1065:1991;121-129.
114. Chou P.Y., Fasman G.D. Conformational parameters for amino acids in helical, β-sheet, and random coil regions calculated from proteins. Biochemistry. 13:1974;211-221.
115. Li S., Deber C.M. Glycine and β-branched residues support and modulate peptide helicity in membrane environments. FEBS Lett. 311:1992;217-220.
116. Popot J.-L., Engelman D.M. Membrane protein folding and oligomerization: The two-stage model. Biochemistry. 29:1990;4031-4036.
117. Engelman D.M., Steitz T.A., Goldman A. Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins. Annu. Rev. Biophys. Biophys. Chem. 15:1986;321-353.
118. Steinhauer D.A., Wharton S.A., Skehel J.J., Wiley D.C. Studies of the membrane fusion activities of fusion peptide mutants of influenza virus hemagglutinin. J. Virol. 69:1995;6643-6651.
119. Wilson I.A., Skehel J.J., Wiley D.C. Structure of the haemagglutinin membrane glycoprotein of Influenza Virus at 3 Å resolution. Nature. 289:1981;366-373.
120. Gray C., Tamm L.K. Structural studies on membrane-embedded Influenza hemagglutinin and its fragments. Prot. Sci. 6:1997;1993-2006.
121. Tatulian S.A., Hinterdorfer P., Baber G., Tamm L.K. Influenza hemagglutinin assumes a tilted conformation during membrane fusion as determined by attenuated total reflection FTIR spectroscopy. EMBO J. 14:1995;5514-5523.
122. Carr C.M., Kim P.S. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell. 73:1993;823-832.
123. Weissenhorn W., Dessen A., Harrison S.C., Skehel J.J., Wiley D.C. Atomic structure of the ectodomain from HIV-1 gp41. Nature. 387:1997;426-430.
124. 2-terminal segment during influenza virus-induced membrane fusion. J. Biol. Chem. 267:1992;20225-20232.
125. Pinter A., Honnen W.J., Tilley S.A., Bona C., Zaghouani H., Gorny M.K., Zolla-Pazner S. Oligomeric structure of gp41, the transmembrane protein of Human Immunodeficiency Virus type 1. J. Virol. 63:1989;2674-2679.
126. Gallaher W.R., Segrest J.P., Hunter E. Are fusion peptides really 'sided' insertional helices? Cell. 70:1992;531-532.
127. Parente R.A., Nir S., Szoka F.C. pH-dependent fusion of phosphatidylcholine small vesicles. Induction by a synthetic amphipathic peptide. J. Biol. Chem. 263:1988;4724-4730.
128. Parente R.A., Nadasdi L., Subbarao N.K., Szoka F.C. Association of a pH-sensitive peptide with membrane vesicles: role of amino acid sequence. Biochemistry. 29:1990;8713-8719.
129. Haensler J., Szoka F.C. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug. Chem. 4:1993;372-379.
130. Takahashi S. Conformation of membrane fusion-active 20-residue peptides with or without lipid bilayers. Implication of α-helix formation for membrane fusion. Biochemistry. 29:1990;6257-6264.
131. Murata M., Takahashi S., Shirai Y., Kagiwada S., Hishida R., Ohnishi S. Specificity of amphiphilic anionic peptides for fusion of phospholipid vesicles. Biophys. J. 64:1993;724-734.
132. Wagner E., Plank C., Zatloukal K., Cotton M., Birnstiel M.L. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: Toward a synthetic virus-like gene-transfer vehicle. Proc. Natl. Acad. Sci. USA. 89:1992;7934-7938.
133. Kemble G.W., Danieli T., White J.M. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell. 76:1994;383-391.
134. Pal R., Barenholz Y., Wagner R.R. Depletion and exchange of cholesterol from the membrane of vesicular stomatitis virus by interaction with serum lipoproteins or poly(vinylpyrrolidone) complexed with bovine serum albumin. Biochemistry. 20:1981;530-539.
135. Phalen T., Kielian M. Cholesterol is required for infection by Semliki Forest virus. J. Cell Biol. 112:1991;615-623.
136. Stegmann T., Morselt H.W.M., Booy F.P., vanBreemen J.F.L., Scherphof G., Wilschut J. Functional reconstitution of influenza virus envelopes. EMBO J. 6:1987;2651-2659.
137. Stecenko A.A., Walsh E.E., Schreier H. Fusion of artificial viral envelopes containing respiratory syncytial virus (RSV) attachment (G) and fusion (F) glycoproteins with Hep-2-cells. Pharm. Pharmacol. Lett. 1:1992;127-129.
138. Plank C., Oberhauser B., Mechtler K., Koch C., Wagner E. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J. Biol. Chem. 269:1994;12918-12924.
139. Mechtler K., Wagner E. Influenza peptide enhanced gene transfer: The role of peptide sequences. N. J. Chem. 21:1997;105-111.